Empagliflozin is a C-glycosyl compound that acts as a sodium-glucose cotransporter 2 inhibitor. It is used as a pharmaceutical raw material in the manufacturing of medications for glycemic control in type 2 diabetes mellitus.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 864070-44-0
Bexagliflozin
pharmaceutical raw material
PMBN
pharmaceutical raw material
Meldonium dihydrate
pharmaceutical raw material
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
pharmaceutical raw material
Fluralaner
pharmaceutical raw material
Peracetyl Empagliflozin
research compound
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
OBWASQILIWPZMG-QZMOQZSNSA-N
C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl